Macfarlanes and White & Case advised Exponent Private Equity on the deal, while Hill Dickinson advised Xeinadin. Exponent Private Equity made a significant investment in the...
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here